| Literature DB >> 33076992 |
Aya Kawasaki1,2, Natsumi Namba3,4, Ken-Ei Sada5,6, Fumio Hirano7,8, Shigeto Kobayashi9, Kenji Nagasaka10, Takahiko Sugihara7,8, Nobuyuki Ono11, Takashi Fujimoto12, Makio Kusaoi13, Naoto Tamura13, Kunihiro Yamagata14, Takayuki Sumida15, Hiroshi Hashimoto16, Shoichi Ozaki17, Hirofumi Makino18, Yoshihiro Arimura19,20, Masayoshi Harigai21, Naoyuki Tsuchiya22,23.
Abstract
BACKGROUND: Interstitial lung disease (ILD) is a severe complication with poor prognosis in anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV). Prevalence of AAV-associated ILD (AAV-ILD) in Japan is considerably higher than that in Europe. Recently, we reported that a MUC5B variant rs35705950, the strongest susceptibility variant to idiopathic pulmonary fibrosis (IPF), was strikingly increased in AAV-ILD patients but not in AAV patients without ILD; however, due to the low allele frequency in the Japanese population, the MUC5B variant alone cannot account for the high prevalence of AAV-ILD in Japan. In this study, we examined whether other IPF susceptibility alleles in TERT and DSP genes are associated with susceptibility to AAV subsets and AAV-ILD.Entities:
Keywords: Microscopic polyangiitis; Myeloperoxidase-ANCA; Polymorphism; Single nucleotide variant; Susceptibility; Vasculitis
Mesh:
Substances:
Year: 2020 PMID: 33076992 PMCID: PMC7574242 DOI: 10.1186/s13075-020-02347-0
Source DB: PubMed Journal: Arthritis Res Ther ISSN: 1478-6354 Impact factor: 5.156
Characteristics in AAV patients and controls
| Characteristics | Groups | Number | Female/male |
|---|---|---|---|
| AAV | |||
| EMA classification | MPA | 315 | 192/123 |
| GPA | 119 | 67/52 | |
| EGPA | 73 | 46/27 | |
| Unclassifiable | 37 | 24/13 | |
| ANCA specificity | MPO-AAV | 432 | 268/164 |
| PR3-AAV | 67 | 33/34 | |
| Presence/absence of ILD in MPO-AAVa | MPO-AAV-ILD | 176 | 101/75 |
| MPO-AAV-noILD | 216 | 139/77 | |
| Controls | HCb | 785 | 478/307 |
| 4.7KJPNc | 4773 | 2641/2130 | |
AAV ANCA-associated vasculitis, EMA European Medicines Agency, MPA microscopic polyangiitis, GPA granulomatosis with polyangiitis, EGPA eosinophilic granulomatosis with polyangiitis, MPO-AAV myeloperoxidase (MPO)-ANCA positive AAV, PR3-AAV proteinase 3 (PR3)-ANCA positive AAV, ILD interstitial lung disease, MPO-AAV-ILD MPO-AAV with ILD, MPO-AAV-noILD MPO-AAV without ILD
aInformation of ILD was not available for 40 patients with MPO-AAV
bHealthy controls recruited by our research group
cAllele frequency data in 4.7KJPN was obtained from the Japanese Multi Omics Reference Panel (jMorp) [22, 23]
Association of TERT and DSP with MPA and MPO-AAV
| OR (95% CI) | OR (95% CI) | |||||||
|---|---|---|---|---|---|---|---|---|
| AAV | ||||||||
| MPA | 427 (0.678) | 351 (0.557) | ||||||
| GPA | 142 (0.597) | 0.82 | 1 | 0.97 (0.75–1.26) | 130 (0.546) | 0.074 | 0.74 | 1.26 (0.98–1.64) |
| EGPA | 101 (0.692) | 0.031 | 0.31 | 1.47 (1.03–2.09) | 77 (0.527) | 0.34 | 1 | 1.17 (0.85–1.63) |
| MPO-AAV | 577 (0.669) | 471 (0.545) | ||||||
| PR3-AAV | 93 (0.694) | 0.034 | 0.34 | 1.49 (1.03–2.15) | 78 (0.582) | 0.03 | 0.3 | 1.46 (1.04–2.07) |
| Controls | ||||||||
| HCa | 965 (0.615) | 791 (0.505) | ||||||
| 4.7KJPNb | 5747 (0.602) | 4628 (0.485) | ||||||
| All controls | 6712 (0.604) | Referent | 5419 (0.488) | Referent | ||||
P values were calculated by chi-square test in comparison between each AAV subset and all controls. Correction for multiple testing was done by Bonferroni correction. Corrected P values (Pc) were calculated by multiplying uncorrected P values by 10. Significant association after correction for multiple testing (Pc < 0.05) is shown in bold
AAV ANCA-associated vasculitis, n allele count, AF allele frequency, MPA microscopic polyangiitis, GPA granulomatosis with polyangiitis, EGPA eosinophilic granulomatosis with polyangiitis, MPO-AAV myeloperoxidase (MPO)-ANCA positive vasculitis, PR3-AAV proteinase 3 (PR3)-ANCA positive vasculitis, HC healthy controls, P corrected P values, OR odds ratio, 95% CI 95% confidence interval
aHealthy controls recruited by our research group
bAllele data in 4.7KJPN was obtained from the Japanese Multi Omics Reference Panel (jMorp) [22, 23]
Association of TERT and DPS with AAV in female and male individuals
| OR (95% CI) | OR (95% CI) | |||||
|---|---|---|---|---|---|---|
| Female | ||||||
| MPA | 260 (0.677) | 0.0014 | 1.43 (1.15–1.78) | 198 (0.516) | 0.35 | 1.10 (0.90–1.36) |
| MPO-AAV | 358 (0.670) | 6.0 × 10−4 | 1.39 (1.15–1.67) | 269 (0.502) | 0.62 | 1.05 (0.88–1.25) |
| Controlsa | 3708 (0.595) | Referent | 3062 (0.491) | Referent | ||
| Male | ||||||
| MPA | 167 (0.679) | 0.049 | 1.32 (1.00–1.73) | 153 (0.622) | 2.3 × 10−5 | 1.76 (1.35–2.29) |
| MPO-AAV | 219 (0.668) | 0.064 | 1.25 (0.99–1.58) | 202 (0.616) | 3.5 × 10−6 | 1.71 (1.36–2.15) |
| Controlsa | 3003 (0.616) | Referent | 2355 (0.484) | Referent | ||
P values were calculated by chi-square test in comparison between each AAV subset and controls
AAV ANCA-associated vasculitis, MPA microscopic polyangiitis, MPO-AAV myeloperoxidase (MPO)-ANCA positive vasculitis, n allele count, AF allele frequency, OR odds ratio, 95% CI 95% confidence interval
aData in controls include allele data in healthy controls and 4.7KJPN obtained from the Japanese Multi Omics Reference Panel (jMorp) [22, 23]
Association study of TERT and DSP in MPO-AAV with ILD
| OR (95% CI) | OR (95% CI) | |||||
|---|---|---|---|---|---|---|
| MPO-AAV-ILD | 230 (0.653) | 0.37 | 0.87 (0.65–1.18) | 198 (0.563) | 0.52 | 1.10 (0.83–1.46) |
| MPO-AAV-noILD | 294 (0.684) | Referent | 233 (0.539) | Referent | ||
P values were calculated by chi-square test in comparison between MPO-AAV-ILD and MPO-AAV-noILD. MPO-AAV myeloperoxidase-ANCA positive vasculitis, ILD interstitial lung disease, MPO-AAV-ILD MPO-AAV with ILD, MPO-AAV-noILD MPO-AAV without ILD, n allele count, AF allele frequency, OR odds ratio, 95% CI 95% confidence interval